The company announced a $350 million public offering on Monday shortly after revealing positive Phase II results for its investigational congenital adrenal hyperplasia drug, with hopes to one day compete with Neurocrine’s Crenessity.
Crinetics Advances Potential Neurocrine Competitor With Fresh Data and Money Read More »
The cardiovascular biotech was also named as one of BioSpace’s top startups to watch on Wednesday.
Corsera Raises $80M as First Preventative Heart Disease Program Moves Into Clinic Read More »
Jazz’s Ziihera and BeOne’s Tevimbra plus chemotherapy led to what Truist Securities dubbed one of the strongest overall survival signals ever reported in a type of gastroesophageal cancer.
Jazz’s Ziihera Shows ‘Practice-Changing’ Efficacy in Stomach Cancer Read More »
Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.
GSK, Ionis Achieve Functional Cure in Hepatitis B Studies, Clearing Path for FDA Run Read More »
The acquisition is centered on Dark Blue Therapeutics’ small-molecule degrader of the MLLT1 and MLLT3 proteins, which is being tested for acute myeloid leukemia.
Amgen Makes Up To $840M Cancer Play With Dark Blue Takeover Read More »
Cartography will hunt for novel tumor antigens, which Pfizer can opt into and advance into clinical development.
Pfizer Searches for Novel Tumor-Selective Antigens With $865M+ Cartography Pact Read More »
Un reciente estudio ha permitido la reconstrucción estructural experimental de las proteínas multiméricas más primitivas hasta la fecha, es decir, aquellas primeras maquinarias construidas a partir de unidades de proteína que se ensamblan para generar una funci&oac …
Reconstruyen los complejos de proteínas más antiguos de la era Precámbrica Read More »
Un estudio revela que el cuerpo utiliza sensores distintos para detectar el frío en la piel y en los órganos internos. Unos investigadores del Instituto de Neurociencias, centro mixto de la Universidad Miguel Hernández de Elche (UMH) y del Consejo Superior de Investigac …
Distintas vías sensoriales para detectar el frío Read More »
Novo Nordisk follows Christmas oral Wegovy approval with quick launch; Eli Lilly is headed for $94.3 billion in annual revenue by 2027, analysts predict; nine more pharmas strike Most Favored Nation deals but half remain unsigned; experts call for stability and rare disease action at FDA, and all eyes are on M&A ahead of the
Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus Read More »
Unos astrónomos han captado y analizado imágenes de dos explosiones estelares, del tipo conocido como nova, muy poco tiempo después de iniciarse y con un nivel de detalle sin precedentes. Esto ha permitido obtener evidencias directas de que estas explosiones son más compl …
Comprueban que las explosiones estelares de tipo nova son más complejas de lo creído Read More »
